The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
The biological behavior of the axially unsymmetric antitumor prodrug (OC-6-44)-acetatodiamminedichloridohydroxidoplatinum(IV), 2, was deeply investigated and compared with that of analogous symmetric Pt(IV) complexes, namely, dihydroxido 1 and diacetato 3, which have a similar structure. The complex...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Bioinorganic Chemistry and Applications |
| Online Access: | http://dx.doi.org/10.1155/2022/3698391 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552735547850752 |
|---|---|
| author | Elisabetta Gabano Ilaria Zanellato Giulia Pinton Laura Moro Mauro Ravera Domenico Osella |
| author_facet | Elisabetta Gabano Ilaria Zanellato Giulia Pinton Laura Moro Mauro Ravera Domenico Osella |
| author_sort | Elisabetta Gabano |
| collection | DOAJ |
| description | The biological behavior of the axially unsymmetric antitumor prodrug (OC-6-44)-acetatodiamminedichloridohydroxidoplatinum(IV), 2, was deeply investigated and compared with that of analogous symmetric Pt(IV) complexes, namely, dihydroxido 1 and diacetato 3, which have a similar structure. The complexes were tested on a panel of human tumor cell lines. Complex 2 showed an anomalous higher cytotoxicity (similar to that of cisplatin) with respect to their analogues 1 and 3. Their reduction potentials, reduction kinetics, lipophilicity, and membrane affinity are compared. Cellular uptake and DNA platination of Pt(IV) complexes were deeply investigated in the sensitive A2780 human ovarian cancer cell line and in the corresponding resistant A2780cisR subline. The unexpected activity of 2 appears to be related to its peculiar cellular accumulation and not to a different rate of reduction or a different efficacy in DNA platination and/or efficiency in apoptosis induction. Although the exact mechanism of cell uptake is not fully deciphered, a series of naïve experiments indicates an energy-dependent, carrier-mediated transport: the organic cation transporters (OCTs) are the likely proteins involved. |
| format | Article |
| id | doaj-art-acfca5be5a154b5b9d035d25b3de3b46 |
| institution | Kabale University |
| issn | 1687-479X |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Bioinorganic Chemistry and Applications |
| spelling | doaj-art-acfca5be5a154b5b9d035d25b3de3b462025-02-03T05:58:01ZengWileyBioinorganic Chemistry and Applications1687-479X2022-01-01202210.1155/2022/3698391The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular UptakeElisabetta Gabano0Ilaria Zanellato1Giulia Pinton2Laura Moro3Mauro Ravera4Domenico Osella5Dipartimento per lo Sviluppo Sostenibile e la Transizione EcologicaDipartimento di Scienze e Innovazione TecnologicaDipartimento di Scienze del FarmacoDipartimento di Scienze del FarmacoDipartimento di Scienze e Innovazione TecnologicaDipartimento di Scienze e Innovazione TecnologicaThe biological behavior of the axially unsymmetric antitumor prodrug (OC-6-44)-acetatodiamminedichloridohydroxidoplatinum(IV), 2, was deeply investigated and compared with that of analogous symmetric Pt(IV) complexes, namely, dihydroxido 1 and diacetato 3, which have a similar structure. The complexes were tested on a panel of human tumor cell lines. Complex 2 showed an anomalous higher cytotoxicity (similar to that of cisplatin) with respect to their analogues 1 and 3. Their reduction potentials, reduction kinetics, lipophilicity, and membrane affinity are compared. Cellular uptake and DNA platination of Pt(IV) complexes were deeply investigated in the sensitive A2780 human ovarian cancer cell line and in the corresponding resistant A2780cisR subline. The unexpected activity of 2 appears to be related to its peculiar cellular accumulation and not to a different rate of reduction or a different efficacy in DNA platination and/or efficiency in apoptosis induction. Although the exact mechanism of cell uptake is not fully deciphered, a series of naïve experiments indicates an energy-dependent, carrier-mediated transport: the organic cation transporters (OCTs) are the likely proteins involved.http://dx.doi.org/10.1155/2022/3698391 |
| spellingShingle | Elisabetta Gabano Ilaria Zanellato Giulia Pinton Laura Moro Mauro Ravera Domenico Osella The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake Bioinorganic Chemistry and Applications |
| title | The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake |
| title_full | The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake |
| title_fullStr | The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake |
| title_full_unstemmed | The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake |
| title_short | The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake |
| title_sort | strange case the unsymmetric cisplatin based pt iv prodrug pt ch3coo cl2 nh3 2 oh exhibits higher cytotoxic activity with respect to its symmetric congeners due to carrier mediated cellular uptake |
| url | http://dx.doi.org/10.1155/2022/3698391 |
| work_keys_str_mv | AT elisabettagabano thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT ilariazanellato thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT giuliapinton thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT lauramoro thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT mauroravera thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT domenicoosella thestrangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT elisabettagabano strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT ilariazanellato strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT giuliapinton strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT lauramoro strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT mauroravera strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake AT domenicoosella strangecasetheunsymmetriccisplatinbasedptivprodrugptch3coocl2nh32ohexhibitshighercytotoxicactivitywithrespecttoitssymmetriccongenersduetocarriermediatedcellularuptake |